GenoMed Inc. (GMED)

[sam1933]

GenoMed forms international partnerships for diabetes prevention
St. Louis Business Journal - by Angela Mueller
Friday, June 26, 2009

GenoMed Inc. is partnering with three companies in the Philippines to help bring a diabetes prevention and management program to the country.

GenoMed, a St. Louis-based medical genomics company, is teaming up with Internet services firm LaSalTech, telecommunications firm Globe Telecom Inc., and retail drug company Mercury Drug to help Filipino patients manage and prevent diabetes via a text messaging and cell phone service. For a flat fee of about $20 a year, patients will be able to be in weekly text and e-mail contact with physicians who would help them use a disease management program developed by GenoMed to help diabetic and potentially diabetic patients avoid dialysis.

Dr. David Moskowitz, chairman and CEO of GenoMed, said he expects the service to launch around July 1.

Moskowitz initially connected with the Filipino partner companies via the LinkedIn social media site. He mentioned an upcoming trip to Malaysia on his LinkedIn profile, and a dialysis nurse from the Philippines contacted him and helped connect him with Rolando Dizon, chairman of LaSalTech.